Egrifta Sv Injection, Form : liquid for Hospital

₹ 25,200 - ₹ 31,500 / Packs

MOQ2 Packs
Formliquid
Usage/ApplicationHospital
Supply TypeExporter, Supplier, Retailer, Distributor
Preferred Buyer Location All over the world

What is EGRIFTA SV (tesamorelin for injection)? EGRIFTA SV or Tesamorelin is an injectable prescription medicine used to reduce excess abdominal fat in adult patients living with HIV and....

Company Information

Member Since 2 Years
Nature of Business Retailer
Year of Establishment 2021

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

What is EGRIFTA SV (tesamorelin for injection)?

EGRIFTA SV or Tesamorelin is an injectable prescription medicine used to reduce excess abdominal fat in adult patients living with HIV and lipodystrophy. EGRIFTA SV^® is a growth hormone-releasing factor (GHRF) analog.
EGRIFTA SV or Tesamorelin is not for weight loss management.
The long-term safety of Tesamorelin on the heart and blood vessels (cardiovascular) is not known.
It is not known whether taking EGRIFTA SV helps improve how well you take your antiretroviral medications.
It is not known if EGRIFTA SV is safe and effective in children, do not use in children.